company background image
NOVT logo

Novanta NasdaqGS:NOVT Voorraadrapport

Laatste prijs

US$164.94

Marktkapitalisatie

US$6.0b

7D

-3.1%

1Y

14.3%

Bijgewerkt

20 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

NOVT Overzicht aandelen

Novanta Inc. levert samen met haar dochterondernemingen precisiegeneeskunde en -productie, medische oplossingen en robotica- en automatiseringsoplossingen in de Verenigde Staten en internationaal. Meer informatie

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Novanta Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Novanta
Historische aandelenkoersen
Huidige aandelenkoersUS$164.94
52 Week HoogtepuntUS$187.12
52 Week LaagUS$142.35
Bèta1.29
11 maand verandering-5.76%
3 maanden verandering-8.66%
1 Jaar Verandering14.32%
33 jaar verandering-3.36%
5 jaar verandering76.26%
Verandering sinds IPO934.91%

Recent nieuws en updates

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Recent updates

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Nov 20
Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Nov 01
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Oct 19
Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Sep 21
Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

Sep 06
Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Aug 19
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Jul 16
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

Jun 06
Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Apr 13
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Mar 29
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

Feb 27
Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Feb 12
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Jan 12
Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Dec 28
We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

Nov 02
Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Oct 03
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Sep 19
With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Aug 23
Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Aug 09

Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Aug 03
Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

Jul 11
Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

Rendement voor aandeelhouders

NOVTUS ElectronicUS Markt
7D-3.1%-1.9%-1.0%
1Y14.3%29.9%30.3%

Rendement versus industrie: NOVT presteerde slechter dan de US Electronic -sector, die het afgelopen jaar een rendement van 29.9 % opleverde.

Rendement versus markt: NOVT presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.3 % opleverde.

Prijsvolatiliteit

Is NOVT's price volatile compared to industry and market?
NOVT volatility
NOVT Average Weekly Movement4.8%
Electronic Industry Average Movement5.9%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: NOVT heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van NOVT is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19682,900Matthijs Glastrawww.novanta.com

Novanta Inc. levert samen met haar dochterondernemingen precisiegeneeskunde en -productie, medische oplossingen en robotica- en automatiseringsoplossingen in de Verenigde Staten en internationaal. Het bedrijf is actief in drie segmenten: Precisiegeneeskunde en Productie, Medische Oplossingen en Robotica en Automatisering. Het segment Precisiegeneeskunde en Productie biedt op fotonica gebaseerde oplossingen, waaronder laserscannen, straalgeleiding, CO2-laser, vastestoflaser, ultrasnelle laser en optische lichtmachines voor op fotonica gebaseerde toepassingen voor industriële verwerking, metrologie, medische en biowetenschappelijke beeldvorming, DNA-sequentiebepaling en medische laserprocedures.

Novanta Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Novanta zich tot de beurswaarde?
NOVT fundamentele statistieken
MarktkapitalisatieUS$5.95b
Inkomsten(TTM)US$60.13m
Inkomsten(TTM)US$922.75m

98.5x

Koers/Winstverhouding

6.4x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NOVT resultatenrekening (TTM)
InkomstenUS$922.75m
Kosten van inkomstenUS$517.88m
BrutowinstUS$404.88m
Overige uitgavenUS$344.74m
InkomstenUS$60.13m

Laatst gerapporteerde inkomsten

Sep 27, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)1.67
Brutomarge43.88%
Nettowinstmarge6.52%
Schuld/Eigen Vermogen Verhouding61.6%

Hoe presteerde NOVT op de lange termijn?

Bekijk historische prestaties en vergelijking